These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 17714902)

  • 1. [Microbiological and pharmacological data useful for the treatment of Lyme disease. Treatment and follow up of early Lyme disease (erythema migrans)].
    Martinot M
    Med Mal Infect; 2007; 37(7-8):394-409. PubMed ID: 17714902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Borrelia afzelii strains to antimicrobial agents.
    Ruzić-Sabljić E; Podreka T; Maraspin V; Strle F
    Int J Antimicrob Agents; 2005 Jun; 25(6):474-8. PubMed ID: 15871918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and follow up of disseminated and late Lyme disease].
    Mohseni Zadeh M
    Med Mal Infect; 2007; 37(7-8):368-80. PubMed ID: 17707605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group.
    Gerber MA; Shapiro ED; Burke GS; Parcells VJ; Bell GL
    N Engl J Med; 1996 Oct; 335(17):1270-4. PubMed ID: 8857006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stage-oriented treatment of Lyme borreliosis].
    Fingerle V; Wilske B
    MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotherapy for early localized Lyme disease].
    Monsel G; Canestri A; Caumes E
    Med Mal Infect; 2007; 37(7-8):463-72. PubMed ID: 17412541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
    Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
    Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility of Borrelia burgdorferi in vitro and in animal models.
    Wretlind B; Johnson RC; Hansen K; Preac-Mursic V
    Scand J Infect Dis Suppl; 1991; 77():143-4. PubMed ID: 1947803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
    Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
    Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis.
    Yang J; Wen S; Kong J; Yue P; Cao W; Xu X; Zhang Y; Chen J; Liu M; Fan Y; Luo L; Chen T; Li L; Li B; Dong Y; Luo S; Zhou G; Liu A; Bao F
    Microbiol Spectr; 2021 Dec; 9(3):e0076121. PubMed ID: 34756070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatological manifestations of Lyme borreliosis.
    Mullegger RR
    Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema migrans in the immunocompromised host.
    Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Lyme disease.
    Goodwin SD; Sproat TT; Russell WL
    Clin Pharm; 1990 Mar; 9(3):192-205. PubMed ID: 2180624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic forms of Borrelia burgdorferi sensu lato: induction, development, and the role of RpoS.
    Murgia R; Piazzetta C; Cinco M
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):574-9. PubMed ID: 12422604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyme disease.
    Berger BW
    Semin Dermatol; 1993 Dec; 12(4):357-62. PubMed ID: 8312152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Lyme borreliosis secondary and tertiary stages].
    Hansmann Y
    Med Mal Infect; 2007; 37(7-8):479-86. PubMed ID: 17367972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Borrelia burgdorferi infection].
    Oteo JA; Martínez de Artola V
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):52-4. PubMed ID: 2029560
    [No Abstract]   [Full Text] [Related]  

  • 19. Lyme meningitis: a one-year follow up controlled study.
    Cimperman J; Maraspin V; Lotric-Furlan S; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):961-3. PubMed ID: 10666809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
    Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A
    Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.